Was ist die Webseite?

TRB Chemedica International

Startseite
Schweiz
Eaux-Vives
TRB Chemedica International

Kontaktinformationen, Karte und Wegbeschreibungen, Kontaktformulare, Öffnungszeiten, Dienstleistungen, Bewertungen, Fotos, Videos und Ankündigungen von TRB Chemedica International, Eaux-Vives.

For over 40 years, TRB Chemedica International have been successfully developing, producing, and promoting APIs, pharmaceutical products, and medical devices in three specialized areas: ophthalmology, rheumatology, and neurology. TRB Chemedica is a Swiss pharmaceutical company, focus on research & development in specific therapeutic areas, including rheumatology, ophthalmology and neurology.

11/09/2025

We’re proud to exhibit at ISIAT 2025, where global experts in intra-articular therapy will explore the latest in viscosupplementation, orthobiologics, and more. From consensus updates to joint preservation in athletes and ultrasound-guided injection workshops, this edition brings valuable insights for specialists in joint and musculoskeletal health.

💬 Meet the at Booth E in Bucharest and discover how our Swiss-engineered solutions are advancing joint care and mobility.

👉 Learn more about our MSK expertise and ISIAT 2025 events https://bit.ly/47ME0lD

04/09/2025

Osteoarthritis in small joints and TMJ can be a real challenge in clinical practice. Here’s a chance to deepen your expertise in just 45 minutes with a leading voice in the field.
📅 Date: Monday, September 29th
⏰ Time: 7:15 – 8:00 PM (CEST)
Join us for a focused clinical webinar on small joint and temporomandibular joint (TMJ) management, led by Stefano Stea, a consultant oral and maxillofacial surgeon in the UK. Register here https://one.wisembly.com/trbacademy

25/08/2025

Mark your calendars and join us at ESCRS 2025 in Copenhagen, from 12–16 September!
We will be exhibiting at Booth C4.018 and are excited to present our latest solutions in ocular surface health.

This year’s congress features exciting extras like the BoSS sustainability track and the 5K Charity Run through Amager Fælled, making it a must-attend event for ophthalmologists committed to innovation and impact. We look forward to connecting with you in Copenhagen!

05/06/2025

Join TRB Chemedica at the EuDEC 2025 in Krakow, June 19-21! Visit us at Booth 9 to explore our trusted solutions and commitment to improving patient care. We're also proud to welcome you on June 21 at 11:30am to our satellite symposium discussing a new European expert consensus on pediatric dry eye.

Find out more https://bit.ly/4jDhSwD

28/05/2025

We’re proud to announce that an e-poster featuring TRB Chemedica’s Ostenil® Plus will be presented at the ISAKOS Congress 2025! The study compares the efficacy of our 2% sodium hyaluronate solution to corticosteroids in isolated patellofemoral osteoarthritis.

Presented by leading experts from Thailand, this research highlights the benefits of Ostenil® Plus in improving patient outcomes.

Visit us at Booth 21 to explore this study and our commitment to advancing musculoskeletal health.

Find out more https://buff.ly/YTZOqz3

14/05/2025

Join us on June 30th from 6 PM to 7 PM (CET) for a TRB Academy webinar featuring Prof. Hirschmüller, renowned expert in sports medicine, orthopedics and traumatology.

📌Topic: Tailoring Injectable Treatments for Tendinopathies:
From Evidence to Clinical Practice

Discover the latest scientific insights and practical approaches for treating tendinopathies with injectable therapies.

🔗Register now
https://buff.ly/pO5XP8l

Be part of the conversation that connects cutting-edge research with hands-on clinical practice.

24/04/2025

Join TRB Chemedica at the Isokinetic Conference in Madrid from May 3-5. Discover our commitment to enhancing musculoskeletal health and improving patient outcomes. As a Swiss-based company, we pride ourselves on our dedication to quality and patient care. Visit us at Booth 29-31 to explore our solutions and engage with our and don't miss the chance to lift a replica of the Champions League cup on our booth! 🏆 😉
Find out more
https://bit.ly/4cO7eRQ

04/04/2025

Join us at the 25th WCO-IOF-ESCEO Congress in Rome! From April 10-13, 2025, visit us at Stand n°2 to learn how TRB Chemedica is advancing care for patients with musculoskeletal diseases. Osteoporosis and osteoarthritis are key focuses for us, and we’re eager to connect with you on this topic. Discover more about our expertise at https://bit.ly/44b2qU9

06/02/2025

Join TRB as our newest Regulatory Affairs Specialist.
Visit https://buff.ly/3CB5zRZ to apply.
We look forward to receiving your application!

06/01/2025

Join TRB as our new Apprenti(e) CFC employé(e) de commerce E- Orientation Finance
https://www.trbchemedica.com/careers/

We look forward to your application!

23/12/2024

Happy season's greetings and best wishes for a new year full of health, happiness and success!

30/10/2024

Join TRB as our new Project coordinator and Data analyst
https://www.trbchemedica.com/careers/

We look forward to your application!

Adresse

Eaux-Vives
<<NOT-APPLICABLE>>

Webseite

https://www.trbchemedica.com/

Benachrichtigungen

Lassen Sie sich von uns eine E-Mail senden und seien Sie der erste der Neuigkeiten und Aktionen von TRB Chemedica International erfährt. Ihre E-Mail-Adresse wird nicht für andere Zwecke verwendet und Sie können sich jederzeit abmelden.

Die Praxis Kontaktieren

Nachricht an TRB Chemedica International senden:

Verknüpfungen

Wollen Sie Ihr Praxis zum Top-Klinik in Eaux-Vives machen?

Notre histoire

We are a market-leading pharma and biotechnology company, based in Switzerland and operating around the world.

Founded by Dr Guido Di Napoli in 1980, TRB Chemedica followed a gradual business evolution and expansion through the development of a worldwide network of subsidiaries and distributors.

For over 30 years, we have been successfully developing, producing, and promoting APIs, pharmaceutical products, and medical devices in three specialized areas: ophthalmology, rheumatology, and neurology.

Our medium-sized company, supported by an exclusive network of affiliates, agents and partners, makes us efficient and responsive in the market, with the ability to develop customized solutions for patients and partners in our three focus areas that are hyluronic acid diacerein and GM1 ganglioside.